Fair Value Calculator Fair Value Calculator
EN DE

1173 (1173) Fair Value & Analysis

Consumer Defensive · Market cap HK$65.5M

1 1173 1173 · HK
PriceHK$0.0260
Fair ValueHK$0.0270
Upside+4.0%
Quality46/100
Evidence: Medium

Fair value as of: Jul 2, 2026

From 10 valuation models · updated today

Share price −7.1% over the past month.

Price vs Fair Value (12 months)

HK$0.0540 HK$0.0230 Fair Value HK$0.0270 Jun 2025 Jun 2026

12‑month range HK$0.0230 – HK$0.0540 · the HK$0.0260 price screens below the HK$0.0270 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1173 (1173) currently trades at HK$0.0260, while our model-based Fair Value estimate is HK$0.0270 — implying the stock looks roughly 4.0% undervalued today. We read business quality at 46/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 1173 generated revenue of HK$421M at a net margin of -25.1%. Revenue declined 10.8% year over year. Net debt stands at HK$586M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$421M
Revenue growth (YoY) -10.8%
Net margin -25.1%
Return on equity -215%
Free cash flow HK$21.5M FY2025
Operating margin -7.4%
More key figures
EPS (TTM) HK$-0.0300
Net debt HK$586M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

1173 reported revenue of HK$421M in FY2026 versus HK$500M in FY2022, a compound −4.2%/yr. Reported net income was −HK$106M in FY2026.

Revenue −4.2%/yr
FY22 HK$500M
FY23 HK$473M
FY24 HK$587M
FY25 HK$481M
FY26 HK$421M
Net income
FY22 −HK$53.4M
FY23 HK$5.0M
FY24 −HK$40.0M
FY25 −HK$125M
FY26 −HK$106M

Is 1173 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
PG PG 2,590 MXN 1,732 MXN -33%
The Procter & Gamble Company PGCO34 R$55.00 R$36.15 -34%
L'Oréal S.A LRLCF $450.56 $209.17 -54%
Unilever PLC UNLYF $59.34 $46.11 -22%
Colgate-Palmolive Company CPA €77.58 €35.72 -54%
Hindustan Unilever Limited HINDUNILVR ₹2,122 ₹677.55 -68%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1173 (1173) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0270 versus a price of HK$0.0260 — about +4% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 1173?
Our model-based fair value for 1173 is HK$0.0270 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0260.
What is the quality score of 1173?
1173 has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1173 (1173)?
1173 reported trailing-twelve-month revenue of about HK$421M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1173?
The net profit margin of 1173 is about -25.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.